The possibility that targeting LAT1 stimulates the compensatory upregulation of a different LAT transporter (i.e., LAT2, LAT3, or LAT4), or a different transporter system (i.e., SNAT amino acid transporters [29]) in certain cancers also warrants investigation. This evidence concerns the gene SLC38A7 and cancer.